Skip to main content

2025 Agenda

Image

Loading

PANEL: Paving the Way Towards Liquid First. Challenges, Opportunities and Reality

June 25, 2025
Cancer Diagnostics Stage
  • Establishing liquid biopsies for early cancer detection and screening.
  • Where can they most provide value. MCEDs currently available? How are liquid biopsies optimising cancer diagnosis.
  • How can we accelerate the development, access and adoption of these tests?
  • Need for collaborative infrastructure for developing standards and best practices + reducing communication barriers. Challenges in establishing liquid biopsies for the betterment of patients e.g. CHIP
Speaker(s)
Lauren Leiman, Executive Director - BLOODPAC
Raluca Budiu-Predoiu, Director of Precision Medicine - AbbVie
Aleksandra Markovets, Director - AstraZeneca